Literature DB >> 874785

Quantitation of the antimalarial agent, mefloquine, in blood, plasma, and urine using high-pressure liquid chromatography.

J M Grindel, P F Tilton, R D Shaffer.   

Abstract

Sensitive and specific assays are described for the quantitation of mefloquine in whole blood, plasma, and urine specimens using high-pressure liquid chromatography. Specimens were extracted with ethyl acetate and concentrated before chromatography. Whole blood and plasma extracts were chromatographed on a polar bonded phase partitioning column, and urine extracts were chromatographed on a bonded reversed-phase partitioning column. The sensitivity of the assays for mefloquine was 0.05 microgram/ml of whole blood or plasma and 0.25 microgram/ml of urine using 5-ml samples. The assays are suitable for studying mefloquine pharmacokinetics in humans.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 874785     DOI: 10.1002/jps.2600660625

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  5 in total

1.  Mefloquine disposition in normals and in patients with severe Plasmodium falciparum malaria.

Authors:  F D Juma; J O Ogeto
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1989 Jan-Mar       Impact factor: 2.441

2.  Depression of human polymorphonuclear leucocyte function by anti-malarial drugs.

Authors:  A Ferrante; B Rowan-Kelly; W K Seow; Y H Thong
Journal:  Immunology       Date:  1986-05       Impact factor: 7.397

Review 3.  Clinical pharmacokinetics of mefloquine.

Authors:  J Karbwang; N J White
Journal:  Clin Pharmacokinet       Date:  1990-10       Impact factor: 6.447

Review 4.  Clinical pharmacokinetics of antimalarial drugs.

Authors:  N J White
Journal:  Clin Pharmacokinet       Date:  1985 May-Jun       Impact factor: 6.447

5.  The pharmacokinetics of mefloquine in man: lack of effect of mefloquine on antipyrine metabolism.

Authors:  J H Rivière; D J Back; A M Breckenridge; R E Howells
Journal:  Br J Clin Pharmacol       Date:  1985-11       Impact factor: 4.335

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.